Optimizing insulin regimens in type 1 diabetes. How to help patients get control of their life.
The advances in insulin therapy in the past 5 years, including the introduction of insulin analogues, have made blood glucose control in patients with type 1 diabetes much more attainable. Diabetic patients can now achieve a better quality of life, including spontaneity and flexibility in lifestyle, than was possible with earlier insulin products. Here, Dr Bohannon discusses the latest improvements in acute and basal insulin therapy and presents three algorithms she has developed to help patients individualize their insulin regimens in relation to their eating and exercise patterns.
Bohannon
Nancy J V
NJ
Monteagle Medical Center, 1580 Valencia St, Suite 504, San Francisco, CA 94110-4415, USA. sugarnancy@pol.net
D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000503:physiopathology; D005934:Glucagon / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D005934:Glucagon